Latest: FDA Approves New Biosimilar for Oncology Treatment

Dr Reddy's Labs CHRO Archana Bhaskar resigns

0 Mins
Hyderabad: Dr Reddy's Labs has announced the resignation of Archana Bhaskar as Chief Human Resources Officer (CHRO) of the Company to pursue other interests. She will cease to be CHRO and Senior Management Personnel of the Company, effective from the close of business hours on November 30, 2025. In a recent BSE filing, the company informed, "We would like to inform that Archana Bhaskar has resigned from the position of Chief Human Resources Officer (CHRO) of the Company." Prior to Dr Reddy's Labs, Archana served various roles at Shell and Unilever. Established in 1984, Dr. Reddy’s Laboratories Ltd. is a global pharmaceutical company headquartered in Hyderabad, India. The Company offers a portfolio of products and services including APIs, generics, branded generics, biosimilars and OTC. Its major therapeutic areas of focus are gastrointestinal, cardiovascular, diabetology, oncology, pain management and dermatology. Dr Reddy's Labs major markets include – USA, India, Russia & CIS countries, China, Brazil and Europe.
Tags:
📢

Advertisement

300x250 Banner

Recent Content

COPD Biologics: Early Treatment Insights

Pulmonology • 2 hours ago

Antihypertensive Medication Guidelines

Cardiology • 4 hours ago

Juvenile Arthritis Care Transition

Rheumatology • 6 hours ago